Return On Assets of Acrivon Therapeutics, Inc. from 30 Jun 2023 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Acrivon Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2023 to 30 Sep 2025.
  • Acrivon Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -48%, a 10% decline year-over-year.
  • Acrivon Therapeutics, Inc. annual Return On Assets for 2024 was -42%, a 8.4% decline from 2023.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Acrivon Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -48% -5% -10% 01 Jul 2025 30 Sep 2025
Q2 2025 -46% -3% -6.9% 01 Apr 2025 30 Jun 2025
Q1 2025 -41% +4% +9% 01 Jan 2025 31 Mar 2025
Q4 2024 -42% -3% -8.4% 01 Oct 2024 31 Dec 2024
Q3 2024 -44% -14% -45% 01 Jul 2024 30 Sep 2024
Q2 2024 -43% -13% -44% 01 Apr 2024 30 Jun 2024
Q1 2024 -45% 01 Jan 2024 31 Mar 2024
Q4 2023 -39% 01 Oct 2023 31 Dec 2023
Q3 2023 -30% 01 Jul 2023 30 Sep 2023
Q2 2023 -30% 01 Apr 2023 30 Jun 2023

Acrivon Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -42% -3% -8.4% 01 Jan 2024 31 Dec 2024
2023 -39% 01 Jan 2023 31 Dec 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.